New York State Teachers Retirement System Sells 24,507 Shares of Hims & Hers Health, Inc. $HIMS

New York State Teachers Retirement System lowered its holdings in Hims & Hers Health, Inc. (NYSE:HIMS) by 12.8% in the 1st quarter, Holdings Channel reports. The firm owned 166,880 shares of the company’s stock after selling 24,507 shares during the period. New York State Teachers Retirement System’s holdings in Hims & Hers Health were worth $3,464,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Farallon Capital Management LLC raised its position in Hims & Hers Health by 30.8% in the 3rd quarter. Farallon Capital Management LLC now owns 10,746,852 shares of the company’s stock worth $609,561,000 after buying an additional 2,533,271 shares during the last quarter. SG Americas Securities LLC lifted its stake in Hims & Hers Health by 25.6% during the 4th quarter. SG Americas Securities LLC now owns 371,553 shares of the company’s stock valued at $12,064,000 after acquiring an additional 75,679 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Hims & Hers Health by 7.2% during the 4th quarter. Vanguard Group Inc. now owns 20,925,666 shares of the company’s stock valued at $679,456,000 after acquiring an additional 1,407,651 shares during the last quarter. Munich Reinsurance Co Stock Corp in Munich purchased a new stake in shares of Hims & Hers Health during the 4th quarter valued at about $11,187,000. Finally, Aquatic Capital Management LLC bought a new stake in shares of Hims & Hers Health in the third quarter worth approximately $5,233,000. 63.52% of the stock is owned by institutional investors.

Hims & Hers Health Trading Down 1.5%

Shares of HIMS stock opened at $35.53 on Friday. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.69 and a quick ratio of 1.56. The company has a market cap of $8.22 billion, a price-to-earnings ratio of -394.80, a PEG ratio of 101.51 and a beta of 2.35. Hims & Hers Health, Inc. has a 1 year low of $13.74 and a 1 year high of $70.43. The firm has a fifty day moving average price of $29.21 and a 200-day moving average price of $26.34.

Hims & Hers Health (NYSE:HIMS) last announced its earnings results on Monday, May 11th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.44). The company had revenue of $608.10 million during the quarter, compared to the consensus estimate of $616.84 million. Hims & Hers Health had a positive return on equity of 6.10% and a negative net margin of 0.56%.Hims & Hers Health’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.20 earnings per share. As a group, equities analysts predict that Hims & Hers Health, Inc. will post 0.03 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Patrick Harrison Carroll sold 23,726 shares of the firm’s stock in a transaction dated Thursday, June 18th. The stock was sold at an average price of $35.00, for a total value of $830,410.00. Following the transaction, the insider owned 181,861 shares of the company’s stock, valued at $6,365,135. This trade represents a 11.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Michael Chi sold 14,027 shares of the firm’s stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of $31.50, for a total value of $441,850.50. Following the completion of the transaction, the chief operating officer directly owned 432,124 shares in the company, valued at $13,611,906. This trade represents a 3.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 167,161 shares of company stock valued at $5,041,152. 11.76% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

HIMS has been the subject of several research reports. Wall Street Zen cut shares of Hims & Hers Health from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. TD Cowen cut their target price on shares of Hims & Hers Health from $25.00 to $23.00 and set a “hold” rating for the company in a research report on Friday, March 27th. UBS Group set a $23.00 target price on shares of Hims & Hers Health in a research note on Friday, May 22nd. Truist Financial increased their price target on Hims & Hers Health from $18.00 to $23.00 and gave the company a “hold” rating in a report on Friday, May 22nd. Finally, Weiss Ratings downgraded Hims & Hers Health from a “hold (c)” rating to a “sell (d)” rating in a research note on Tuesday, May 12th. Four investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Hims & Hers Health has a consensus rating of “Hold” and a consensus target price of $30.70.

About Hims & Hers Health

Hims & Hers Health, Inc is a telehealth platform providing direct-to-consumer personal care products and virtual medical services in the United States. Operating under the Hims & Hers brand, the company offers an integrated digital experience that connects users with licensed healthcare providers, enabling online consultations and prescriptions for a range of conditions. Its telemedicine infrastructure supports both prescription medications and over-the-counter products, with home delivery to patients’ doorsteps.

The company’s product portfolio addresses key areas of men’s and women’s health, including hair loss treatments, sexual wellness therapies, skincare regimens and mental health support.